Literature DB >> 6432041

Covalent binding efficiency of the third and fourth complement proteins in relation to pH, nucleophilicity, and availability of hydroxyl groups.

S K Law, T M Minich, R P Levine.   

Abstract

The binding of [3H]glycerol and [3H]putrescine to C3 was studied in a fluid-phase system using trypsin as the C3 convertase. The binding of glycerol showed little variation in the pH range between 6.0 and 10.0. The binding of putrescine (pKa = 9.0) is rather ineffective below pH 7.5 but becomes more efficient as the pH of the reaction mixture increases. These results agree with the contention that the final step of the binding reaction is the transfer of the acyl group of the exposed thio ester of C3 to a nucleophile since the nucleophilicity of hydroxyl groups is rather independent of pH whereas only the unprotonated form of amino groups is nucleophilic. The inefficient reaction of amino groups with the exposed thio ester of C3 is also supported by the study of the inhibitory activity of serine and its two derivatives, N-acetylserine and O-methylserine, to the binding of [3H]glycerol to C3. N-Acetylserine showed an inhibitory activity equivalent to that of serine, whereas O-methylated serine showed only minimal activity. It can be concluded, therefore, that serine reacts with the thio ester of C3 by its hydroxyl group but not by its alpha-amino group. The ability of the alcohol group of various alkanes to inhibit the binding of [3H]glycerol to C3 was also studied. The primary alcohols inhibit the binding reaction with an efficiency that is similar to glycerol, and there are no significant differences in the binding efficiencies of methanol, ethanol, 1-propanol, and 1-butanol.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432041     DOI: 10.1021/bi00309a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

Review 1.  The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?

Authors:  Richard A Harrison
Journal:  Semin Immunopathol       Date:  2017-11-22       Impact factor: 9.623

2.  Decreased infectivity despite unaltered C3 binding by a DeltahbhA mutant of Mycobacterium tuberculosis.

Authors:  Stacey L Mueller-Ortiz; Eliud Sepulveda; Margaret R Olsen; Chinnaswamy Jagannath; Audrey R Wanger; Steven J Norris
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Covalent binding properties of the human complement protein C4 and hydrolysis rate of the internal thioester upon activation.

Authors:  A Sepp; A W Dodds; M J Anderson; R D Campbell; A C Willis; S K Law
Journal:  Protein Sci       Date:  1993-05       Impact factor: 6.725

4.  Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation.

Authors:  A Sahu; T R Kozel; M K Pangburn
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

5.  Amino acid sequence of the trypsin-generated C3d fragment from human complement factor C3.

Authors:  U Hellman; G Eggertsen; A Engström; J Sjöquist
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

6.  Combined familial C7 and C4B deficiency in an adult with meningococcal disease.

Authors:  H M Chapel; T E Peto; G A Luzzi; R A Thompson; A H Fielder; J R Batchelor
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

7.  The complement component C4 of mammals.

Authors:  A W Dodds; S K Law
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

8.  The purification and properties of some less common allotypes of the fourth component of human complement.

Authors:  A W Dodds; S K Law; R R Porter
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

9.  Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity.

Authors:  C Y Yu; K T Belt; C M Giles; R D Campbell; R R Porter
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

10.  The origin of the very variable haemolytic activities of the common human complement component C4 allotypes including C4-A6.

Authors:  A W Dodds; S K Law; R R Porter
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.